Physician profile
Trisha D Cubb
NPI 1124394317
$4,309.15
in general payments reported to CMS, 2019-2025
17 companies · $251 in 2025
The $251 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $249 · 2020: $112 · 2021: $1,394 · 2022: $1,661 · 2023: $347 · 2024: $296 · 2025: $251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $894.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $893.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $2,361.85 | 2020-2023 | Tepezza |
| Abbott Laboratories | $338.24 | 2020-2024 | Freestyle Libre |
| Novo Nordisk INC | $297.59 | 2021-2024 | Wegovy, Rybelsus, Ozempic |
| Dexcom, INC. | $217.02 | 2021-2023 | Dexcom G6 Transmitter |
| Tempus Ai, INC | $198.87 | 2024 | |
| Exelixis INC. | $175.00 | 2025 | Cabometyx |
| Astrazeneca Pharmaceuticals LP | $141.44 | 2019-2022 | |
| Abbvie INC. | $135.48 | 2019-2024 | |
| Lilly USA, LLC | $133.28 | 2021-2022 | |
| Medtronic, INC. | $121.73 | 2022 | |
| Eisai INC. | $75.79 | 2025 | |
| Corcept Therapeutics | $47.82 | 2023 | Korlym |
| Novartis Pharmaceuticals Corporation | $23.02 | 2022 | |
| Grt US Holding, INC. | $14.86 | 2022 | |
| Amgen INC. | $13.89 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $13.27 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Trisha Cubb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.